Globachem joined the biofungicide developer's investor base in a series B round that included several of the company's series A investors.

Belgium-based biopesticide developer AgroSavfe has completed a €7.8m ($8.6m) series B round featuring agrochemical producer Globachem. Globachem took part in the round alongside life sciences research institute VIB, private equity firm Gimv, Flemish-focused fund PMV, Madeli Participaties, university commercialisation fund Qbic Fund and Biovest, the investment vehicle of Rudi Mariën, AgroSavfe was spun out of…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.